Furthermore, we found that HSP90 inhibitors reduced the levels of Fanconi anemia factors such as FANCA, defining a plausible mechanism of how HSP90 inhibition compromises the repair of platinum-DNA adducts and thus sensitizes the cells towards cisplatin. Here, FANCA is linked to Fanconi anemia.